Isotretinoin for Proliferative Vitreoretinopathy
NCT01445028
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
109
Enrollment
OTHER
Sponsor class
Conditions
Proliferative Vitreoretinopathy
Interventions
DRUG:
Isotretinoin
Sponsor
Wills Eye